Skip to Main Content

Paper Details

Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management.
EBioMedicine
5
2022
FADS1, HMGCR, LDL-C, PCSK-9i, PCSK9, Statins, T2D, Triglyceride, icosapent ethyl, proprotein convertase subtilisin/kexin type-9, statins, triglycerides, type 2 diabetes
Author NameAffiliation
Nikhil K KhankariVanderbilt University Medical Center, USA Vanderbilt Genetics Institute
Megan M ShueyVanderbilt Genetics Institute, Vanderbilt University Medical Center
Shoa L ClarkeStanford University School of Medicine
Julie A LynchUSA College of Nursing and Health Sciences, University of Massachusetts
Marijana VujkovicUniversity of Pennsylvania Perelman School of Medicine, USA Corporal Michael J. Crescenz VA Medical Center
Todd L EdwardsVanderbilt Genetics Institute, Vanderbilt University Medical Center, USA Nashville VA Medical Center
  • 1 - 6

Datasets